Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Liver Metastasis Colon Cancer × FOLFOXIRI protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 3 Neoplasms 1 Liver Metastasis Colon Cancer 1 Carcinoma, Neuroendocrine 1

Interventions

Bevacizumab 2 regorafenib 1 Oxaliplatin 1 IFL protocol 1 FOLFOXIRI protocol 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04832776 2021-04-06

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Fudan University

Phase 2 Unknown

Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡